Even though the loss of SOCS1 did not correlate with increased MET or p21 expression as we had expected, our findings support the tumor suppressor function of SOCS1, and the oncogenic potential of MET and p21 in PCa. Here, CDKN1A is linked to posterior cortical atrophy.